cryptocurrency high People also ask

Contemporary Amperex Technology Co., Limited applied for the trademark of "Chargeo Charging Dog", and the intellectual property information of Tianyancha shows that recently, Contemporary Amperex Technology Co., Limited New Energy Technology Co., Ltd. applied for the registration of three trademarks of "Chargeo Charging Dog", which are internationally classified as transportation, scientific instruments and building repair, and the current trademark status is awaiting substantive examination. According to media reports, "CharGo charging dog" is a storage, charging and inspection integrated robot developed by Contemporary Amperex Technology Co., Limited. The charging dog has three functions in one. It is not only a mobile charging facility, but also a distributed energy storage, and it is also a battery safety guardian of new energy vehicles.Musk: Grok can now generate four images at the same time and render them step by step.Zhongke Lanxun: The cooperation between the company and the bean bag model will be carried out in multiple stages. Zhongke Lanxun released the record of investor relations activities. In order to meet the increasing demand for AI headsets in the market, the company has carried out in-depth cooperation with Volcano Engine, a cloud service platform owned by ByteDance. The third-generation BT895x chip of Xunlong Company has completed the docking with the MaaS platform of Volcano Ark, and has been able to provide users with software and hardware solutions adapted to the large model of bean curd. The cooperation between the company and the bean bag model will be carried out in multiple stages. At this stage, the functions of real-time translation, meeting minutes, real-time dialogue and so on have been adapted. Later, both parties will introduce more AI functions in different usage scenarios. In the future, the company will continue to lay out the field of AI wearable products, continue to cooperate deeply with the big model of bean bags, and introduce AI wearable solutions with better user experience to the market.

Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.On the 13th, SSE 50 index futures fell by 2.58%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, SSE 50 index futures closed at 2,412, up or down by -2.58%, with a turnover of 53,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7,398 lots. The total number of contracts of SSE 50 index futures was 91,500 lots, an increase of 25,700 lots over the previous day. The first 20 seats in the contract held 88,200 lots, an increase of 2,257 lots over the previous day. The short positions in the top 20 seats of the contract were 113,700 lots, an increase of 1,701 lots over the previous day. (Sina Futures)The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion yuan for the 53rd consecutive trading day.

He ertai bought 199 million yuan and sold 155 million yuan in Shenzhen Stock Connect today. He ertai bought 199 million yuan and sold 155 million yuan today, with a turnover of 6.304 billion yuan and a turnover rate of 3.727%. After-hours data showed that the special seats of Shenzhen Stock Connect bought 199 million yuan and sold 155 million yuan.Fabian Russell, National Secretary of the French communist party: Call on the new Prime Minister not to use special constitutional power to make new legislation. In this case, we are ready to cooperate with the new Prime Minister Bayrou.Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.